Dabogratinib is an orally active, selective inhibitor for FGFR3 with an IC50 of 11 nM in Ba/F3. Dabogratinib exhibits antitumor efficacy against urothelial cancers and solid tumors[1].
Molecular Weight:
559.47
Purity:
99.90
CAS Number:
[2800223-30-5]
Formula:
C25H24Cl2N6O3S
Target:
FGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted